Epstein Barr Virus (EBV) is a herpesvirus that is universally acquired by age 3-4 and is the cause of infectious mononucleosis. It is transmitted through oral secretions and body fluids. EBV has a double-stranded DNA genome and its major structural components include capsid proteins of 160, 47, and 28 kD and tegument proteins of 152 kD. EBV establishes lifelong latency in B cells and has been linked to several cancers like Burkitt's lymphoma, Hodgkin's disease, T-cell lymphomas, and nasopharyngeal carcinoma. While treatment is usually supportive, prevention focuses on minimizing exposure and developing effective vaccines.
Epstein Barr Virus (EBV) is a herpesvirus that is universally acquired by age 3-4 and is the cause of infectious mononucleosis. It is transmitted through oral secretions and body fluids. EBV has a double-stranded DNA genome and its major structural components include capsid proteins of 160, 47, and 28 kD and tegument proteins of 152 kD. EBV establishes lifelong latency in B cells and has been linked to several cancers like Burkitt's lymphoma, Hodgkin's disease, T-cell lymphomas, and nasopharyngeal carcinoma. While treatment is usually supportive, prevention focuses on minimizing exposure and developing effective vaccines.
Epstein Barr Virus (EBV) is a herpesvirus that is universally acquired by age 3-4 and is the cause of infectious mononucleosis. It is transmitted through oral secretions and body fluids. EBV has a double-stranded DNA genome and its major structural components include capsid proteins of 160, 47, and 28 kD and tegument proteins of 152 kD. EBV establishes lifelong latency in B cells and has been linked to several cancers like Burkitt's lymphoma, Hodgkin's disease, T-cell lymphomas, and nasopharyngeal carcinoma. While treatment is usually supportive, prevention focuses on minimizing exposure and developing effective vaccines.